Ia region gene products have long been postulated to be antigen-binding (recognition) molecules (1); in particular, one set of hypotheses suggests that they are participants along with a T cell product in the antigen-binding complex (2, 3). It has recently been observed that certain T cell clones will react to antigen in association with two different major histocompatibility complex (MHC) 1 haplotypes, but in doing so these clones display different antigen specificities (4, 5). Such results have been interpreted as support for the above hypothesis. In the present work we have subjected the postulate to a further test by attempting to identify the site on a peptide antigen that interacts with the Ia molecule (i.e. controls the specificity changes that accompany the changes of MHC type) and the presumably different site that interacts with the T cell (i.e. contributes to immune memory).
APC. Subsequently, Heber-Katz et al. (6) have extended these observations by showing that peritoneal exudate T lymphocytes (PETLES) from pigeon-primed B10.A and moth-primed B10.A(5R) mice behave in a manner indistinguishable from the T cell hybridomas when antigen responses with different APC were tested.
These observations provide the means for identifying two different functional sites on the pigeon cytochrome c fragment. They can be used to locate the site wherein moth and pigeon differ structurally, which prevents the pigeon fragment from being presented to these T cells by B10.A(5R) APC. There is a second site, functionally defined by T cell memory and shared by the moth and pigeon fragments, to which this population of T cells has been primed. In the present work synthetic peptides were prepared and tested in order to identify these two sites.
The difference between the moth and pigeon peptides that controlled APC functions was found to be at residue 103. At this position the pigeon sequence contains alanine, which is deleted from the moth peptide. The site of T cell memory was also identified. By introducing changes in the lysines at 99 and 103 and at 99 alone, two additional pairs of antigen peptides were made, each pair consisting of otherwise homologous sequences with and without alanine-103. The immune response pattern of the B10.A(5R) was duplicated for these new antigens; the B10.A(5R) was a low responder to the alanine-103 containing peptides, but a high responder to the des-Ala l°a peptides. When B 10.A(SR) mice were primed with the des-Ala 1°3 peptides, the two new antigens did not crossreact with des-Alal°3-pigeon 81-104 or with each other. The mothlike (desAla ~°~) and pigeonlike forms of these two new antigens were found to behave just as the moth and pigeon fragments themselves behaved when tested for their ability to be presented by either B10.A or B10.A(5R) APC. Thus, both forms were presented by the B10.A APC but only mothlike, des-Ala ~°s peptides were presented to the B10.A(5R) T cells by syngeneic APC. When these experiments were extended by testing T lymphocyte hybridoma clones similar behavior of the Ala ~°3 deletion was observed. However, additional residues also appeared to be able to affect the APC's function.
A prominent and interesting feature of our initial studies was that the T cell populations from the B10.A and B10.A(5R) primed to pigeon 81-104 and moth 81-103, respectively appeared to be equivalent. We naturally wished to see whether this equivalence extended to the new antigens. For the new antigen in which lysine-99 was replaced by glutamine, the B 10.A and B 10.A(5R) repertoires were found not to be symmetrical. Rather the B10.A(SR) APC presented both the Alal°3-Gln 99 and des-Alal°3-Gln 99 antigens to B 10.A T cells primed with the Alal°3-Gln 99. Since the B10.A(5R) was a low responder to the Alal°S-Gln 99 antigen, these data indicate that while Ir differences to some antigens (e.g., pigeon and moth) are expressed solely in the APC, this is not invariably the case. Antigens. Preparation of antigens has been described elsewhere (7) . Briefly, the carboxyl terminal cyanogen bromide fragment from pigeon (Columbia livia) was prepared from the isolated protein, kindly provided by Dr. E. Margoliash, Northwestern University, Evanston, IL. The other peptides were synthesized by the method of Merrifield as described previously (5) except that the tyrosine hydroxyls were protected as 2,6-dichlorobenzyl ethers and the amide functions were protected as the 9-xanthenyl amido ester (8) . Peptides having 16 or fewer residues could be purified from the hydrogen fluoridetreated solid-phase reaction mixture by a single gel-filtration chromatography step (Sephadex G-25, fine, 2.5 x 100 cm) in 5% (vol/voi) acetic acid. The larger peptides were further purified on CM-BioGel A as previously described. The acetimidyl derivatives were prepared by reaction of the peptide with methyl acetimidate HCI (Aldrich Chemical Co., Milwaukee, WI). The conditions used allowed reaction only with the primary amino groups, thereby converting each lysine into an analogue of homoarginine.
Materials and Methods

Preparation and Culture of Peritoneal Exudate T Lymphocyte-enriched Cells (PETLES).
PETLES were prepared as previously described (9) . Animals were immunized in the hind foot pad with antigen and complete Freund's adjuvant followed 10 d later by an injection of 1.0 ml 10% (wt/voi) Brewer's thioglycolate medium intraperitoneaily. After 5 d, exudate cells were removed from the peritoneum and passed over nylon wool. 5 x 104 nylon wool passed iymphocytes were cultured in 0.2 ml Eagle's Hanks amino acids medium (EHAA) containing 10% fetal bovine serum and varying numbers of antigen.pulsed presenting cells. After 90 h of culture 1 •Ci of [SH]thymidine was added to each culture and 6 h later the cultures were harvested using a MASH II (MA Bioproducts, Walkersville,
MD).
Preparation of Antigen-presenting and an Antigen-pulsing Procedure. According to the method of DeFranco (10) spleens were teased, washed twice with l~hosphate-buffered saline without Ca *+ or Mg++(PBS) (MA Bioproducts) and then 5 x 107 cells were layered in 3 ml of PBS above 3 ml of a solution (Percoll, 10X PBS, PBS-9:I:10 [vol/vol]) and then centrifuged for 12 min at 4°C at 2,000 g. The cells that banded at the PBS/Percoll interface were greatly enriched for antigen-presenting activity (L. Glimcher, unpublished observation). These were washed three times with PBS, and cultured with antigen 15 h at 37°C in complete medium, washed six times and then irradiated (2,000 R).
Preparation of T Cell Hybridomas and Assessment of
Antigen-specific Stimulation. T cell hybridomas were made as described previously (5, 11, 12) . Briefly, lymph node T cell cultures stimulated with antigen for 3 d were fused with BW5147 and selected by growth in hypoxanthine, aminopterin, thymidine (HAT) medium. Fusion products were cloned by limiting dilution on a thymocyte feeder layer. Antigen specificity was tested by first culturing 5 x 104-105 T cell hybrids and 5 × 105 X-irradiated spleen cells in 0.25 ml of fusion medium without HAT for 2 d with varying amounts of antigen. The supernatant from these cultures was harvested and added to an equal volume of complete EHAA in a second culture to assess IL2 production. This culture contained 3 × l0 s HT-2 cells, a T cell line developed by Dr. J. D. Watson, Auckland U. Sch. of Med., whose growth is completely dependent on IL2 (a kind gift of Drs. Kappler and Marrack, Natl. Jewish Hosp., Denver, CO).
[SH]thymidine was added 24 h later to measure proliferation.
Lymph Node Proliferation Assay. Lymph node proliferation assays were done as previously reported (7) . Animals were immunized in complete Freund's adjuvant in the hind footpads. Popliteal and inguinal lymph nodes were collected 7-9 d later, teased, and passed over nylon wool. The 4 x 10~nylon wool passed lymph node cells plus 1 x 105 irradiated (2,000 R) normal spleen cells were cultured with varying amounts of antigen and pulsed with 1 pCi of [3H]thymidine and harvested.
Results
The primary goal of this work was to identify which of the five structural differences between the moth and pigeon cytochrome c peptides (see Table I) ANTIGEN-PRESENTING CELL-EXPRESSED SPECIFICITY 
* The single letter code is used: A, alanine; D, aspartic acid; E, glutamic acid; F, phenylalanine; G, glycine; I, isoleucine; K, lysine; L, ieucine; N, asparagine; Q, glutamine; R, arginine; T, threonine; V, valine; Y, tyrosine; A, deletion.
prevented B10.A(5R) APC from presenting the pigeon peptide. Earlier analysis (10) of the pigeon cytochrome c peptide antigen had shown that changes at residues 100 and 104 could strongly affect antigen function. Thus, we focused initially on the deletion at position 103. In order to examine the contribution of this structural change, we synthesized two des-Ala-pigeon peptides, DAP87 and DAPsl (see Table I ), which were identical in sequence to pigeon except at 103, where they both lacked an alanine. Fig. 1A shows that moth-primed B10.A(5R) lymph node cells responded to both these synthetic peptides, DAPsl and DAP87, almost as well as they responded to the moth fragment immunogen and 10,000-fold better than they responded to the pigeon fragment. Thus, the secondary response of moth-primed B10.A(5R) T-cells showed this strain to be a high responder to DAP81 and DAP87 but not to pigeon. Fig. 1B shows the results of the test of B10.A(5R) DAPslprimed lymph node cells. A strong secondary response to DAP81 was seen that cross-reacted fully with moth 81-103 (Ms1) and moth 88-103 (Mss) but not with AmMss or pigeon 81-104 (P). These results therefore show that it is solely the presence of the Ala 1°3 that prevents the pigeon peptide from being a strong antigen or immunogen in B 10.A(5R) mice.
Previously it has been demonstrated (6) that there is an antigen-specific defect in B10.A(5R) APC in that they present the pigeon fragment 81-104 poorly to pigeon-primed B10.A peritoneal exudate T lymphocytes (PETLES) but can present Ms1 to this population. We naturally wished to determine whether this antigen-specific defect in presentation to B10.A T cells also depended on the Ala 1°~ deletion. The data in Table II showed this to be the case. Pigeon-primed B10.A PETLES were stimulated with APC-enriched BI0.A and B10.A(5R) splenocytes that had been precultured with either moth, pigeon, or DAP8~ fragments (antigen pulsed) or with medium control. The B10.A APC caused marked stimulation with all three of the test peptides. B10.A(5R) APC caused proliferation with DAP81 and moth; however, there was no B10.A(5R)-pigeon response above the medium control. Thus, the Ala 1°3 residue prevented the effective presentation of the pigeon peptide by B10.A(5R) APC in this case to Table I . ! PETLES cultures were harvested on to glass filters and counted. Mean _+ SEM (x 10 -s) of triplicate cultures are given.
allogeneic B10.A T cells. We next considered whether this APC defect represents a change in specificity of the immune response or merely a change in its sensitivity. This latter possibility was suggested by the observations that higher doses of moth fragment are required to prime B10.A(5R) than the B10.A (data not shown) and that lymph Whether there was also a specificity change could be considered by noting that in moth-primed B 10.A(5R) mice the acetimidyl derivative of moth 81-103 (Ammoth) is a weak antigen but clearly stronger than pigeon (Fig. 1A) ; while in a pigeon or moth-primed B 10.A, the pigeon 81-104 peptide is a stronger antigen than Am-moth (data not shown). If a change of relative strengths of these antigens were found when B10.A and B10.A(5R) antigen-pulsed APC were compared, this would be evidence of a change in specificity. Fig. 2 reports the response curves of moth-primed B 10.A(5R) PETLES to antigen-pulsed B 10.A APC. There is clearly a reversal of the relative strengths of pigeon 81-104 (P) and acetimidyl moth between Fig. 1 A and Fig. 2 . Results from this type of experiment are summarized in Table III. Shown in Table III , Exp. I is a comparison of the response of moth-primed PETLES to Am-moth and pigeonpulsed B10.A and B10.A(5R) APC and illustrates the reversal of pigeon and Am-moth. The reciprocal experiment using Am-moth primed B10.A(5R) and Am-pigeon primed B10.A PETLES was performed and yielded an identical result (Table III, Exps. II and III). In these experiments B10.S(9R) APC were also tested. These APC failed to present the Am-pigeon fragment to any appreciable extent, indicating that the altered specificity was not the result of an allogeneic effect. These results made clear that there was a difference in the specificity of the B10.A(5R) PETLES response to B10.A and B10.A(5R) APC.
The results in Table III further suggested that the role of Ala ~°3 in governing the ability of B10.A and B10.A(5R) APC remained unchanged when two Otherwise as in Table II dyl-Gln -des-Ala -splice (AmDAQ) from each other and from des-Ala -pigeon (DAPsz). B10.A(5R) mice were primed with 50 #g of AmDASp(A) or AmDAQ99(B) and then tested as in Fig. 1 . Antigen identification is given in Table I . Media controls: A, 2,000 _ 100; B, 2,900 ± 600; PPD stimulation: A, 72,500 4-16,500; B, 106,900 + 10,000. Tables II and III. both Ala]°3-containing and des-Alal°~-peptides while the B10.A(5R) APC were able to stimulate only with the des-Ala 1°3 form. C57B1/10 and B10.A(4R)/(IE b) APC were not able to stimulate at all, indicating that the AeE~ Ia molecule was utilized. Likewise B10.S(9R)(IE k) APC failed to present, indicating that even among mice expressing an AeE~ molecule antigen recognition was MHC restricted. Taken together, the data presented above indicate that for three separate T cell specificities (Lys 99, Am-Lys 99, Gln 99) there was a consistent antigen-specific defect in the ability of the B10.A(5R) APC's function, namely its disruption by the Ala l°s insertion. That this defect lay in the APC was established by the B10.A APC's ability to present the Ala~°3-containing peptides to the same T cell population. These data suggest that there is an interaction between the restriction element (the AeE~ Ia molecule in this case) and nominal antigen. It must be considered that all the residues on the nominal antigen that participate in this interaction cannot be defined with present techniques. The identification of the site of this interaction depends on the availability of an MHC degenerate T cell. Even so, only the differences in antigen-MHC interaction between the degenerate haplotypes can be identified. The previous data make clear that there was a difference between B10.A and B10.A(5R) in their ability to tolerate the insertion of Ala 1°3. The B10.A was permissive for this change. The B 10.A(5R) was restrictive. In contrast acetimidylation of the ~-amino groups had in these experiments a pronounced effect on the T cell clones activated, i.e., on T cell memory, but did not appear to affect the antigen-MHC interaction.
TABLE IV
B I O.A( 5R) PETLES Respond to Ala ~°~-Containing Peptides with BIO.A but Not BIO.A(5R) APC*
We next considered the possibility that different T cell clones might reveal different APC polymorphisms. This possibility was explored using two hybridoma clones. The first, labeled A in Table V, A. Yet, the ability of B10.A(5R) to present the acetimidyl peptides to some T cells, e.g., our clone A, but not clone B indicates that the MHC-controlled, APC-expressed specificity of the antigen-MHC interaction might be determined, in part, by the T cell population.
This question, i.e., the relationship between the T cell and the antigen-MHC interaction site that can serve that T cell, can perhaps be better answered by knowing the correlation between the MHC-controlled APC-expressed antigen specificity and immune responsiveness. If one assumes that the interaction between antigen and MHC was for the most part independent of the T cell population, then, since B10.A(5R) APC were unable to present the Ala 1°3 containing peptides to des-Alal°3-primed B10.A(5R) T cells, one would expect that the B10.A(5R) should be a low responder to all these peptides. The data presented in Table VI test this hypothesis. It shows that B10.A(5R) responded, in general, very poorly to the Alal°Lcontaining peptides. The largest response, to the moths6_90, pigeon94-104 splice peptide (Sp) was roughly two-fifths that of PPD, while responses to the des-Alal°3-peptides were usually twice that. Further, no response to the Alal°Lcontaining peptides was seen at 1.0 #M while responses to mice primed to the des-Alal°S-peptides were evident as low as 10 -1 #M (Figs.  1 and 3 ). Lastly, the low level of the B10.A(5R) anti-Sp response has not allowed Table II. us to test its specificity beyond noting that there is no heteroclitic stimulation by DASp. In particular, there is no evidence that the site of T cell memory contains residue-99. Thus, there is an excellent correlation between the low immune responsiveness of B10.A(5R) to the Alal°3-containing peptides and the poor ability of its APC to present them to des-Ala~°~-primed T cells. A marked response to the AmQ 99 peptide in B10.A and B 10.S(9R) mice could be obtained. ~ If immune response differences do in fact reflect only the capacity of the APC to interact with antigen, and this capacity were independent of the T cell test population, one would excpect that B10.A(5R) APC would present AmDAQ 99 but not AmQ 99 to AmQ99-primed B10.A PETLES. The data presented in Table VII show three experiments in which this was not the case. Rather, there was significant and largely equivalent presentation of both AmQ 99 and AmDAQ 99 to some fraction of the BI0.A PETLES even though the B 10.A(5R) was essentially a nonresponder to AmQ 99 and a strong responder to AmDAQ 99. Again B10.A(4R) failed to present, indicating a requirement for the AeE~ Ia molecule. Note particularly that Table II and Table VII present comparable experiments examining the effects of the Ala ~°3 insertion on the ability of B10.A(5R) APC to present two different antigens to B10.A T cells. The results found were, in fact, opposite: B10.A(5R) APC can present AmQ 99 but not the pigeon 81-104 fragment. These data suggest that there may be two mechanism of Ir gene effects. For one type, of which the B10.A(5R) poor response to pigeon 81-104 is an example, low responsiveness is explicable solely on the basis of the APC-expressed antigen specificity. For the second type, e.g., B10.A(5R) anti-AmQ 99, both repertoire and APC specificity appear to be involved.
Discussion
The data presented in this work address two questions: Does the B10.A(5R)'s low responsiveness to the Ala~°3-containing peptides correlate with some limitation of its APC function? If so, is this the only cause of the B10.A(5R) low responsiveness?
The answer to the first question is emphatically yes. The correlation between the B10.A(5R)'s poor responsiveness to the Ala~°3-containing peptides as immunogens and the poor response of des-Alal°3-primed B10.A(5R) PETLES to the Ala~°3-containing peptides on B10.A(5R) but not B 10.A APC is the fundamental observation of the present work. As has been reported previously (7, 13) and in Table VI of this report, B10.A(5R) is a low but not a complete nonresponder to the five Ala~°S-containing peptides tested (pigeon, Am-pigeon, splice, AmSp, and AmQ99). In each case the B10.A(5R) T cells that have been primed with a desAla~°3-peptide are able to respond well to the Alal°3-containing peptides when B10.A APC are used, but poorly with its own B10.A(5R) APC. From the examination of the B10.A(5R) PETLES we might conclude that there is an antigen-specific defect of the presenting cell with an antigen structure-function relationship that is independent of the specificity of the T cell clone used to detect it. Although most of our data indicated that the APC-expressed antigen specificity did not depend on the test T cell population, analysis of the hybridoma clone B yielded an apparent exception. However, this exception is difficult to interpret because it was revealed by peptides that had been modified by acetimidate at two sites: residue-99, the site of T cell memory, and the carboxyl terminus. The resulting specificity pattern is fairly complex. Although clone B responds to neither AmDAP or Am-moth fragment 81-103 on B10.A(5R) APC, it is not completely unresponsive to peptides with Am-Lys at 99 and 103. For example, it responds well to Am-fly fragment 81-103 in association with B10.A(5R) APC (5). Because, in this case, changes in specificity and sensitivity can not be carefully separated, we feel the question of whether additional residues affect APC-expressed antigen specificity should be deferred until further data can be obtained.
Examination of the immune response to the peptides with Gin 99 addresses the second question: whether the APC-expressed antigen specificity is the exclusive cause of Ir gene effects. As is shown by the comparison of Table VII and Table  IV , the T cell repertoires to the Gin99-containing peptides appear to differ between B10.A and B10.A(5R). The B10.A possesses clones that can respond to AmQOg-B 10.A(5R) but the B10.A(5R) does not. This result is completely analogous to the earlier reports of allogeneic T cells being able to respond to antigen on low responder APC (14) (15) (16) (17) (18) . The difference is that previously low responder APC, allogeneic to the T cell source, were used for both priming and the secondary assay; whereas, in the present case, the degeneracy of the B10.A antiAmQ 99 T cells allowed syngeneic priming. In either case, the data indicate that differences in T cell repertoires can be the cause of Ir gene effects.
In our opinion, the significant points to be made from the present work are as follows. Duplicate experiments have been performed with two different pairs of antigens: (a)pigeon/des-Alal°~-pigeon; (b)AmDAQ99/AmQ 99. In the first case the immune response differences between B 10.A and B 10.A(5 R) appear entirely attributable to APCoexpressed antigen specificity. The second case is clearly more complex. Examination of the B10.A(5R) anti-AmDAQ 99 response reveals the same APC-expressed antigen specificity as seen in (1) . However, examination of the B10.A anti-AmQ 99 response indicates additional clones are present for this antigen in the B 10.A that are absent in the B 10.A(5R). Thus APC-expressed antigen specificity is demonstrable and correlates with differences in immune responsiveness, but is not the sole cause of immune response polymorphisms.
Lastly, some brief speculation on the mechanism of MHC-controlled, APCexpressed specificity may be useful. The simplest, and therefore most attractive, hypothesis is that the nominal antigen and the Ia region gene products physically interact through a site that contains the Alal°3-deletion (6) and that the site on the nominal antigen of this interaction depends only on the location of the site of T cell memory (the T cell epitope), not on its particular structure. In the present case the putative site of interaction would be characterized by the B 10.A's ability to accept Ala ~°s or its deletion while the B10.A(5R) is apparently able to present only the des-Ala-peptides well. The hypothesis is in good agreement with all the data except the AmQ99-primed B10.A T cell subpopulation, which recognizes AmQ 99 and AmDAQ 99 equally well with B10.A(5R) APC. Further investigations to determine which residues, in addition to 99, contribute to the site of T cell memory will allow us to compare the location and extent of the T cell epitope for clones both of the B10.A anti-Lys 99 and the B10.A anti-Gin 99 responses that recognize antigen in association with B10.A(5R). These data should provide a further test of the hypothesis.
Summary
In previous work (5, 6), we have reported studies on a T lymphocyte hybridoma clone and the peritoneal exudate T cells (PETLES) from B 10.A(5R) mice primed with the cytochrome c carboxyl terminal peptide (residues 81-103) of the tobacco horn worm moth (Manducca sextus). As expected, since B10.A(5R) is a low responder to pigeon fragment 81-104, it was found that the B 10.A(5R) lymphocytes were unable to respond to the pigeon cytochrome c 81-104 fragment presented on syngeneic B10.A(5R) antigen-presenting cells (APC). However, these same T lymphocytes did respond to the pigeon fragment when presented on B10.A APC. Thus, some structural difference between the pigeon and moth peptides had prevented B 10.A(5R) APC from effectively presenting the pigeon fragment to moth-primed B10.A(5R) lymphocytes. This structural difference was found to be the deletion of an alanine at position -103 (Ala 1°3) from the pigeon sequence in the moth peptide. Two additional T cell specificities were created by changing residue-99. These T cell populations from the B10.A(5R) showed an identical dependence on the Ala 1°3 deletion when B10.A and B 10.A(5R) APC were compared.
The relationship of APC-expressed antigen specificity and MHC-linked immune responsiveness differences was also examined. The B10.A(5R) was found to be a high responder to each of three peptides that lack Ala ~°3 but not to the Ala~°3-containing analogues. B10.A mice, in contrast, respond to both types of peptides. Utilizing ailogeneic antigen-presentation to B10.A PETLES by pulsed APC, it was shown that the poor response of the B10.A(5R) to the Ala ~°~-containing peptides was, in two of three cases, not associated with any differences in T cell repertoires but due to two different APC capabilities of B10.A and B10.A(5R). The exception apparently represents a case of T cell repertoire polymorphism between B10.A and B10.A(5R) that can also affect immune responsiveness.
